Trial Profile
Clinical pharmacology studies of oral, enteric-coated buprenorphine in patients with opioid dependence.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 23 Apr 2015
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary)
- Indications Opioid-related disorders
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Relmada Therapeutics
- 23 Apr 2015 New trial record